AGL three-lens brief
Evidence-based stock research on AGL. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA above 200-day MA (golden-cross regime); price above both. · RSI at 77 — technically overbought.
- 50-day MA above 200-day MA (golden-cross regime); price above both.
- RSI at 77 — technically overbought.
- Outperforming SPY by 44.6pp over 30 days.
- Negative free cash flow last quarterly (-$120.64M).
- Reported earnings on 2026-11-04.
AGL closed at $114.81 (+1.14%) as of 2026-11-12. Market cap: $1.93B. Price is above the 50-day MA and above the 200-day MA. Positives: 50-day MA above 200-day MA (golden-cross regime); price above both.; outperforming SPY by 44.6pp over 30 days.. Concerns: rSI at 77 — technically overbought.; negative free cash flow last quarterly (-$120.64M).. Last quarter: Revenue $1.52B, net income $34.91M, free cash flow -$120.64M.
Why three lenses on AGL, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AGL across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/AGL" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AGL brief"></iframe>